In a groundbreaking advancement in oncology, a new cancer drug is changing the future for patients diagnosed with advanced head and neck cancer. The immunotherapy drug, pembrolizumab, has shown remarkable success in doubling the average time patients remain cancer-free, offering new hope to those facing this aggressive disease. A Game-Changer in Head and Neck Cancer […]